OTC Markets EXMKT - Delayed Quote USD

Rafina Innovations Inc. (VICA)

0.0001
0.0000
(0.00%)
At close: May 14 at 4:00:00 PM EDT
Loading Chart for VICA
  • Previous Close 0.0000
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0030
  • Volume 10,116
  • Avg. Volume 3,413
  • Market Cap (intraday) 366,067
  • Beta (5Y Monthly) 7.88
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VICA

View More

Performance Overview: VICA

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

VICA
0.00%
S&P 500 (^GSPC)
0.19%

1-Year Return

VICA
0.00%
S&P 500 (^GSPC)
12.31%

3-Year Return

VICA
98.94%
S&P 500 (^GSPC)
46.44%

5-Year Return

VICA
99.18%
S&P 500 (^GSPC)
106.58%

Compare To: VICA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VICA

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -599.91%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    335.15k

  • Net Income Avi to Common (ttm)

    -5.78M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.26k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.05M

Research Analysis: VICA

View More

Company Insights: VICA

Research Reports: VICA

View More

People Also Watch